Financial incentive: Difference between revisions
mNo edit summary |
mNo edit summary |
||
| Line 34: | Line 34: | ||
* Nerve blocks | * Nerve blocks | ||
== Profit from harvested foreskins== | == Profit from harvested foreskins == | ||
Foreskins are sold to pharmaceutical companies for stem-cell research, the creation of synthetic skin, and the creation of consumer products. Since the 1980s, private hospitals have been involved in the business of supplying discarded foreskins to private bio-research laboratories and pharmaceutical companies who require human flesh as raw research material.<ref>A short history of the institutionalization of involuntary sexual mutilation in the United States. Hodges F. in: Denniston GC, Milos MF (eds). Sexual Mutilations: A Human Tragedy. New York: Plenum Press. 1997:17-40.</ref> They also supply foreskins to transnational corporations. Dr. Tania Phillips, professor of dermatology at Boston University of Medicine, insisting foreskin gathering and cultivating is scientifically and technologically "very promising." <ref>Ronald Rosenberg. 19 October 1992: 22-23.</ref> | Foreskins are sold to pharmaceutical companies for stem-cell research, the creation of synthetic skin, and the creation of consumer products. Since the 1980s, private hospitals have been involved in the business of supplying discarded foreskins to private bio-research laboratories and pharmaceutical companies who require human flesh as raw research material.<ref>A short history of the institutionalization of involuntary sexual mutilation in the United States. Hodges F. in: Denniston GC, Milos MF (eds). Sexual Mutilations: A Human Tragedy. New York: Plenum Press. 1997:17-40.</ref> They also supply foreskins to transnational corporations. Dr. Tania Phillips, professor of dermatology at Boston University of Medicine, insisting foreskin gathering and cultivating is scientifically and technologically "very promising." <ref>Ronald Rosenberg. 19 October 1992: 22-23.</ref> | ||
=== Corporate | === Corporate benefactors === | ||
The following transnational corporations reap corporate profits from the sale of marketable products made from harvested human foreskins: | The following transnational corporations reap corporate profits from the sale of marketable products made from harvested human foreskins: | ||